@article{e84a7d84604a44be8ce9795b3fd5c287,
title = "Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies",
author = "Avirup Guha and Derbala, {Mohamed H.} and Qiuhong Zhao and Wiczer, {Tracy E.} and Woyach, {Jennifer A.} and Byrd, {John C.} and Awan, {Farrukh T.} and Daniel Addison",
note = "Funding Information: Please note: This work was supported in part by a National Institutes of Health P50-CA140158 award, as well as by K23 CA178183, R01 CA197870, R35 CA197734, and K12-CA133250 grants; the D. Warren Brown Foundation; and the Four Winds Foundation. Dr. Byrd has received research funding from Acerta Pharma, Pharmacyclics, Inc., and Genentech. Dr. Awan has been a consultant for Gilead Sciences, Pharmacyclics, Inc., Janssen, AbbVie, and Novartis Oncology. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors acknowledge and thank the patients and their families treated at The Ohio State University Comprehensive Cancer Center. The paper{\textquoteright}s content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ",
year = "2018",
month = aug,
day = "7",
doi = "10.1016/j.jacc.2018.06.002",
language = "English (US)",
volume = "72",
pages = "697--698",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "6",
}